Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By



This article was originally published in The Tan Sheet

Executive Summary

JAMA July 11 article on herbals and perioperative care "speculative" and unscientific, group says. Study's recommendations to discontinue garlic use seven days prior to surgery "controversial," AHPA contends, saying data were limited to one anomalous case-study. Association maintains JAMA review "might be best repeated by researchers with a stronger knowledge of herbs," but says article's advice to improve patient-physician communication on preoperative herbal use is worthy of "embrace by the medical community" (1"The Tan Sheet" July 16, p. 7)

You may also be interested in...

Valerian, Kava Anesthetic Interaction Potential Cited In JAMA Review

Valerian supplement doses should be tapered off several weeks before surgery to avoid potential withdrawal symptoms in patients who have become physically dependent on the botanical, Michael Ang-Lee, MD, University of Chicago, et al., state in the July 11 Journal of the American Medical Association.

People In Brief

Perrigo promotes in pricing, planning

In Brief

Combe sells most of its OTC brands





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts